BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19125012)

  • 1. Medullary thyroid cancer: early detection and novel treatments.
    Roman S; Mehta P; Sosa JA
    Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope.
    Deshpande HA; Gettinger SN; Sosa JA
    Curr Opin Oncol; 2008 Jan; 20(1):19-24. PubMed ID: 18043252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of medullary thyroid cancer.
    Milan SA; Sosa JA; Roman SA
    Minerva Chir; 2010 Feb; 65(1):27-37. PubMed ID: 20212415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary thyroid carcinoma and biomarkers: past, present and future.
    van Veelen W; de Groot JW; Acton DS; Hofstra RM; Höppener JW; Links TP; Lips CJ
    J Intern Med; 2009 Jul; 266(1):126-40. PubMed ID: 19522831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of medullary thyroid carcinoma.
    Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.
    Kraeber-Bodéré F; Salaun PY; Oudoux A; Goldenberg DM; Chatal JF; Barbet J
    Cancer; 2010 Feb; 116(4 Suppl):1118-25. PubMed ID: 20127952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
    Cerrato A; De Falco V; Santoro M
    J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell.
    Austin JR; el-Naggar AK; Goepfert H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):611-27. PubMed ID: 8844733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma and hormones.
    Cohen R; Quidville V; Bihan H
    Ann Med Interne (Paris); 2003 Mar; 154(2):109-16. PubMed ID: 12746649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
    Castellani MR; Seregni E; Maccauro M; Chiesa C; Aliberti G; Orunesu E; Bombardieri E
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):430-40. PubMed ID: 19088696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
    Schlumberger MJ; Elisei R; Bastholt L; Wirth LJ; Martins RG; Locati LD; Jarzab B; Pacini F; Daumerie C; Droz JP; Eschenberg MJ; Sun YN; Juan T; Stepan DE; Sherman SI
    J Clin Oncol; 2009 Aug; 27(23):3794-801. PubMed ID: 19564535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatment of medullary thyroid cancer.
    Sugawara M; Geffner DL; Martinez D; Hershman JM
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):367-72. PubMed ID: 19633548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary thyroid cancer: therapeutic targets and molecular markers.
    Ball DW
    Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
    Santarpia L; Ye L; Gagel RF
    J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.
    Cheung K; Roman SA; Wang TS; Walker HD; Sosa JA
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2173-80. PubMed ID: 18364376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma: surgical treatment advances.
    Dionigi G; Bianchi V; Rovera F; Boni L; Piantanida E; Tanda ML; Dionigi R; Bartalena L
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):877-85. PubMed ID: 17555398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medullary thyroid cancer--screening].
    Hansen HS
    Ugeskr Laeger; 1994 Jun; 156(26):3893-6. PubMed ID: 8059474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary, anaplastic, and metastatic cancers of the thyroid.
    Pitt SC; Moley JF
    Semin Oncol; 2010 Dec; 37(6):567-79. PubMed ID: 21167376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.